翔宇醫療(688626.SH):在腦機接口領域佈局較早,目前仍以非侵入式為主
格隆匯10月22日丨翔宇醫療(688626.SH)在互動平台表示,公司在腦機接口領域佈局較早,目前仍以非侵入式為主,公司已申報了眾多專利,且已有專利獲得授權,各項工作正在有序推進:1、產品:腦電採集裝置,針對新生兒腦監測、大腦注意力問題、焦慮、抑鬱及情緒控制等問題,形成腦功能診療一體的解決方案,產品已進入註冊檢測階段,預計明年上半年開始陸續取證;2、自主技術及人才:引入國內精神心理領域知名專家,吸納掌握腦機接口技術的資深技術人員,加速公司多通道的腦電信息採集裝置的取證速度及自研產品上市進程;3、產學研:與天津大學、西安交通大學等聯合承擔多項國家重點專項,與西安交通大學成立康復研究院、註冊成立陝西子公司,聚焦腦機接口、人工智能等前沿技術領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.